Mesoblast (ASX: MSB) Share Price

MSB

$1.95▼-1.02%

$2.52BRank #187 on ASXHealthcareBiotechnology

Prices updated 13 June 2026, 9:40 am AEST · Data: Financial Modeling Prep

Market Cap

$2.52B

Volume

2.2M

P/E Ratio

EPS

$0.00

Dividend Yield

0.00%

52-Week High

$3.31

52-Week Low

$1.5275

Beta

0.793

Mesoblast (ASX: MSB) is an Australian-listed company in the Healthcare sector with a market capitalisation of $2.52B and the 187th-largest security on the ASX by market capitalisation. The MSB share price is $1.95, down 1.02% today and up 5.95% over the past 12 months. Shares have traded between $1.5275 and $3.31 over the past 52 weeks. In its most recent reported period (ending 30 June 2025), Mesoblast reported revenue of $7.0M and a net loss of $27.1M.

Charts

$1.96

24H Range

$1.95

$1.997

52-Week Range

$1.5275

$3.31

About Mesoblast Limited

Mesoblast Limited, an Australian enterprise established in Melbourne in 2004, is dedicated to developing innovative regenerative medicine products. The company's global reach extends to the United States, Singapore, the United Kingdom, and Switzerland. Its therapeutic endeavors encompass a wide array of medical conditions, including cardiovascular diseases, spinal and orthopedic ailments, oncology, hematology, and immune-mediated and inflammatory disorders. Mesoblast's distinctive regenerative medicine platform is founded on the therapeutic potential of specialized mesenchymal lineage cells. A prominent candidate, Remestemcel-L, is currently in late-stage (Phase III) clinical trials for various systemic inflammatory conditions, such as steroid-refractory acute graft versus host disease, acute respiratory distress syndrome, and biologic-refractory inflammatory bowel disease. Additionally, Remestemcel-L is undergoing Phase III evaluation for chronic heart failure and chronic low back pain linked to degenerative disc disease. The company's pipeline also features MPC-300-IV, under development for biologic-refractory rheumatoid arthritis and diabetic nephropathy, and MPC-25-IC, aimed at treating or preventing acute myocardial infarction. Mesoblast has forged key strategic partnerships, including one with Tasly Pharmaceutical Group for the commercialization of MPC-150-IM (for heart failure) and MPC-25-IC (for heart attacks) in China. It also collaborates with JCR Pharmaceuticals Co. Ltd. on wound healing therapies for epidermolysis bullosa patients, and with Grünenthal to advance and market a cell therapy for chronic low back pain.

IPO Date

15 Dec 2004

CEO

Silviu Itescu

Employees

Website

mesoblast.com

Key Financial Data

Revenue (Quarterly)	$7.0M
Net Income (Quarterly)	$-27.1M
Total Assets	$782.3M
Total Debt	$135.1M
Free Cash Flow	$-4.5M
Return on Equity	0.00%
Profit Margin	-386.04%
Operating Margin	-489.49%

MSB Frequently Asked Questions

What is the Mesoblast (ASX: MSB) share price?

The MSB share price is $1.95, down 1.02% for the day, based on the latest available ASX market data.

What is Mesoblast's market capitalisation?

Mesoblast has a market capitalisation of $2.52B, making it the 187th-largest security listed on the ASX.

Does Mesoblast pay a dividend?

MSB does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Mesoblast profitable?

In its most recent reported period (ending 30 June 2025), MSB reported revenue of $7.0M and a net loss of $27.1M.

How many MSB shares are on issue?

Mesoblast has approximately 1,292,825,537 shares on issue, based on its market capitalisation of $2.52B and current share price.

What sector is Mesoblast in?

Mesoblast is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Mesoblast list on the ASX?

Mesoblast listed on the Australian Securities Exchange on 15 Dec 2004.

Latest News

Does Mesoblast (ASX:MSB) Deserve a Spot on Your Healthcare Watchlist?

Kalkine25 May 2026

Does Mesoblast (ASX:MSB) Deserve a Spot on Your Healthcare Watchlist? Kalkine

Mesoblast Limited (ASX:MSB): Are Analysts Optimistic?

Yahoo Finance11 Nov 2025

Mesoblast Limited (ASX:MSB): Are Analysts Optimistic? Yahoo Finance

Mesoblast Limited (ASX:MSB) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

simplywall.st1 Sept 2025

Mesoblast Limited (ASX:MSB) Consensus Forecasts Have Become A Little Darker Since Its Latest Report simplywall.st

Mesoblast (ASX:MSB) Delivers 60% Jump in Ryoncil Sales, Strengthening Commercial Momentum

Stocks Down Under9 Jan 2026

Mesoblast (ASX:MSB) Delivers 60% Jump in Ryoncil Sales, Strengthening Commercial Momentum Stocks Down Under

Mesoblast shares: Ryoncil® underpins strong earnings growth

The Motley Fool Australia7 Apr 2026

Mesoblast shares: Ryoncil® underpins strong earnings growth The Motley Fool Australia

Similar Companies

Company	Market Cap	Price	P/E	Div Yield	1D Change
NEUNeuren Pharmaceuticals Limited	$1.69B	$13.39	38.25	0.00%	▲+0.60%
SNZSummerset Group Holdings Limited	$1.68B	$6.93	5.59	0.47%	▼-0.57%
CU6Clarity Pharmaceuticals Ltd	$801.9M	$2.15	-5.54	0.00%	▲+4.37%
PYCPYC Therapeutics Limited	$711.3M	$1.22	-10.86	0.00%	▲+3.39%
SPLStarpharma Holdings Limited	$286.2M	$0.68	27.58	0.00%	▲+1.49%
DXBDimerix Limited	$99.1M	$0.165	-5.17	0.00%	▼-2.94%
ILAIsland Pharmaceuticals Limited	$95.0M	$0.38	-5.66	0.00%	▲+7.04%
IMMImmutep Limited	$69.3M	$0.047	-3.40	0.00%	–+0.00%

ETFs That Hold MSB

MSB is held by 10 ASX-listed funds tracked on this site. The largest allocation is in iShares S&P/ASX Small Ordinaries ETF (ASX: ISO) at 0.74% of its portfolio.

Fund	Portfolio Weight	Fund Size
ISOiShares S&P/ASX Small Ordinaries ETF	0.74%	$134.5M
FAIRBetaShares - Australian Sustainability Leaders ETF	0.57%	$1.10B
VSOVanguard MSCI Australian Small Companies Index ETF	0.40%	$1.18B
EX20BetaShares - Australian Ex-20 Portfolio Diversifier ETF	0.25%	$662.3M
A200BetaShares - Australia 200 ETF	0.09%	$10.05B
VASVanguard Australian Shares Index ETF	0.09%	$26.10B
AUSTBetaShares - Managed Risk Australian Shares Complex ETF	0.09%	$33.0M
IOZiShares Core S&P/ASX 200 ETF	0.08%	$8.88B
GEARBetaShares - Geared Australian Equities Complex ETF	0.06%	$592.6M
QOZBetaShares - FTSE RAFI Australia 200 ETF	0.01%	$1.21B

Largest Healthcare Stocks on the ASX

Company	Market Cap	Price	1Y Change
CSLCSL Limited	$51.49B	$107.51	▼-55.35%
RMDResMed Inc.	$40.21B	$27.72	▼-28.70%
SIGSigma Healthcare Limited	$30.48B	$2.64	▼-18.01%
FPHFisher & Paykel Healthcare Corporation Limited	$18.93B	$32.23	▼-5.74%
PMEPro Medicus Limited	$17.13B	$164.00	▼-41.41%
MPLMedibank Private Limited	$13.69B	$4.97	▲+1.22%
SHLSonic Healthcare Limited	$9.98B	$20.20	▼-24.66%
RHCRamsay Health Care Limited	$8.93B	$38.82	▲+5.16%
COHCochlear Limited	$6.79B	$103.75	▼-62.07%
TLXTelix Pharmaceuticals Limited	$4.61B	$13.60	▼-47.02%

Browse all ASX sectors

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$1.995	$1.997	$1.95	$1.96	1.9M	▼-0.25%
11 June 2026	$1.98	$2.005	$1.925	$1.965	2.9M	▼-2.72%
10 June 2026	$2.06	$2.06	$2.01	$2.02	1.4M	▼-1.70%
9 June 2026	$1.99	$2.09	$1.96	$2.055	3.7M	▲+0.24%
8 June 2026	$2.09	$2.12	$2.03	$2.05	3.4M	▲+0.99%
5 June 2026	$2.09	$2.12	$2.03	$2.03	2.9M	▲+0.50%
4 June 2026	$2.00	$2.03	$1.985	$2.02	2.2M	▼-0.74%
3 June 2026	$2.02	$2.06	$1.985	$2.035	3.1M	▼-0.73%
2 June 2026	$2.10	$2.105	$2.00	$2.05	3.1M	▼-2.84%
1 June 2026	$2.13	$2.17	$2.09	$2.11	1.8M	–+0.00%
29 May 2026	$2.04	$2.12	$2.03	$2.11	1.3M	▲+3.94%
28 May 2026	$2.05	$2.07	$2.01	$2.03	940K	▼-1.46%
27 May 2026	$2.08	$2.13	$2.05	$2.06	1.8M	▼-1.90%
26 May 2026	$2.12	$2.12	$2.05	$2.10	1.1M	▼-0.94%
25 May 2026	$2.12	$2.14	$2.08	$2.12	1.4M	–+0.00%
22 May 2026	$2.10	$2.15	$2.09	$2.12	1.8M	▲+2.42%
21 May 2026	$2.06	$2.12	$2.03	$2.07	2.4M	▲+3.50%
20 May 2026	$2.05	$2.08	$1.99	$2.00	1.6M	▼-1.96%
19 May 2026	$2.05	$2.08	$2.02	$2.04	1.1M	–+0.00%
18 May 2026	$2.11	$2.11	$2.02	$2.04	1.9M	▼-2.86%
15 May 2026	$2.07	$2.13	$2.07	$2.10	1.9M	▲+2.94%
14 May 2026	$2.04	$2.055	$1.995	$2.04	2.1M	–+0.00%
13 May 2026	$1.985	$2.05	$1.98	$2.04	1.9M	▲+2.26%
12 May 2026	$2.00	$2.00	$1.93	$1.995	2.7M	▼-0.75%
11 May 2026	$2.00	$2.02	$1.935	$2.01	3.5M	▼-0.99%
8 May 2026	$2.04	$2.07	$2.01	$2.03	1.6M	▼-2.17%
7 May 2026	$2.15	$2.15	$2.07	$2.075	1.8M	▼-1.19%
6 May 2026	$2.22	$2.22	$2.09	$2.10	3.5M	▼-3.67%
5 May 2026	$2.20	$2.22	$2.17	$2.18	1M	▼-0.46%
4 May 2026	$2.18	$2.23	$2.18	$2.19	810K	▼-0.68%

About Mesoblast Limited

IPO Date

15 Dec 2004

CEO

Silviu Itescu

Employees

Website

mesoblast.com

MSB Frequently Asked Questions

What is the Mesoblast (ASX: MSB) share price?

The MSB share price is $1.95, down 1.02% for the day, based on the latest available ASX market data.

What is Mesoblast's market capitalisation?

Mesoblast has a market capitalisation of $2.52B, making it the 187th-largest security listed on the ASX.

Does Mesoblast pay a dividend?

MSB does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.

Is Mesoblast profitable?

In its most recent reported period (ending 30 June 2025), MSB reported revenue of $7.0M and a net loss of $27.1M.

How many MSB shares are on issue?

Mesoblast has approximately 1,292,825,537 shares on issue, based on its market capitalisation of $2.52B and current share price.

What sector is Mesoblast in?

Mesoblast is classified in the Healthcare sector, within the Biotechnology industry on the ASX.

When did Mesoblast list on the ASX?

Mesoblast listed on the Australian Securities Exchange on 15 Dec 2004.

Company

Market Cap

Price

P/E

Div Yield

1D Change

NEUNeuren Pharmaceuticals Limited

$1.69B

$13.39

38.25

0.00%

▲+0.60%

SNZSummerset Group Holdings Limited

$1.68B

$6.93

5.59

0.47%

▼-0.57%

CU6Clarity Pharmaceuticals Ltd

$801.9M

$2.15

-5.54

0.00%

▲+4.37%

PYCPYC Therapeutics Limited

$711.3M

$1.22

-10.86

0.00%

▲+3.39%

SPLStarpharma Holdings Limited

$286.2M

$0.68

27.58

0.00%

▲+1.49%

DXBDimerix Limited

$99.1M

$0.165

-5.17

0.00%

▼-2.94%

ILAIsland Pharmaceuticals Limited

$95.0M

$0.38

-5.66

0.00%

▲+7.04%

IMMImmutep Limited

$69.3M

$0.047

-3.40

0.00%

–+0.00%

Fund

Portfolio Weight

Fund Size

ISOiShares S&P/ASX Small Ordinaries ETF

0.74%

$134.5M

FAIRBetaShares - Australian Sustainability Leaders ETF

0.57%

$1.10B

VSOVanguard MSCI Australian Small Companies Index ETF

0.40%

$1.18B

EX20BetaShares - Australian Ex-20 Portfolio Diversifier ETF

0.25%

$662.3M

A200BetaShares - Australia 200 ETF

0.09%

$10.05B

VASVanguard Australian Shares Index ETF

0.09%

$26.10B

AUSTBetaShares - Managed Risk Australian Shares Complex ETF

0.09%

$33.0M

IOZiShares Core S&P/ASX 200 ETF

0.08%

$8.88B

GEARBetaShares - Geared Australian Equities Complex ETF

0.06%

$592.6M

QOZBetaShares - FTSE RAFI Australia 200 ETF

0.01%

$1.21B

Company

Market Cap

Price

1Y Change

CSLCSL Limited

$51.49B

$107.51

▼-55.35%

RMDResMed Inc.

$40.21B

$27.72

▼-28.70%

SIGSigma Healthcare Limited

$30.48B

$2.64

▼-18.01%

FPHFisher & Paykel Healthcare Corporation Limited

$18.93B

$32.23

▼-5.74%

PMEPro Medicus Limited

$17.13B

$164.00

▼-41.41%

MPLMedibank Private Limited

$13.69B

$4.97

▲+1.22%

SHLSonic Healthcare Limited

$9.98B

$20.20

▼-24.66%

RHCRamsay Health Care Limited

$8.93B

$38.82

▲+5.16%

COHCochlear Limited

$6.79B

$103.75

▼-62.07%

TLXTelix Pharmaceuticals Limited

$4.61B

$13.60

▼-47.02%

Historical Prices

Date	Open	High	Low	Close	Volume	Change %
12 June 2026	$1.995	$1.997	$1.95	$1.96	1.9M	▼-0.25%
11 June 2026	$1.98	$2.005	$1.925	$1.965	2.9M	▼-2.72%
10 June 2026	$2.06	$2.06	$2.01	$2.02	1.4M	▼-1.70%
9 June 2026	$1.99	$2.09	$1.96	$2.055	3.7M	▲+0.24%
8 June 2026	$2.09	$2.12	$2.03	$2.05	3.4M	▲+0.99%
5 June 2026	$2.09	$2.12	$2.03	$2.03	2.9M	▲+0.50%
4 June 2026	$2.00	$2.03	$1.985	$2.02	2.2M	▼-0.74%
3 June 2026	$2.02	$2.06	$1.985	$2.035	3.1M	▼-0.73%
2 June 2026	$2.10	$2.105	$2.00	$2.05	3.1M	▼-2.84%
1 June 2026	$2.13	$2.17	$2.09	$2.11	1.8M	–+0.00%
29 May 2026	$2.04	$2.12	$2.03	$2.11	1.3M	▲+3.94%
28 May 2026	$2.05	$2.07	$2.01	$2.03	940K	▼-1.46%
27 May 2026	$2.08	$2.13	$2.05	$2.06	1.8M	▼-1.90%
26 May 2026	$2.12	$2.12	$2.05	$2.10	1.1M	▼-0.94%
25 May 2026	$2.12	$2.14	$2.08	$2.12	1.4M	–+0.00%
22 May 2026	$2.10	$2.15	$2.09	$2.12	1.8M	▲+2.42%
21 May 2026	$2.06	$2.12	$2.03	$2.07	2.4M	▲+3.50%
20 May 2026	$2.05	$2.08	$1.99	$2.00	1.6M	▼-1.96%
19 May 2026	$2.05	$2.08	$2.02	$2.04	1.1M	–+0.00%
18 May 2026	$2.11	$2.11	$2.02	$2.04	1.9M	▼-2.86%
15 May 2026	$2.07	$2.13	$2.07	$2.10	1.9M	▲+2.94%
14 May 2026	$2.04	$2.055	$1.995	$2.04	2.1M	–+0.00%
13 May 2026	$1.985	$2.05	$1.98	$2.04	1.9M	▲+2.26%
12 May 2026	$2.00	$2.00	$1.93	$1.995	2.7M	▼-0.75%
11 May 2026	$2.00	$2.02	$1.935	$2.01	3.5M	▼-0.99%
8 May 2026	$2.04	$2.07	$2.01	$2.03	1.6M	▼-2.17%
7 May 2026	$2.15	$2.15	$2.07	$2.075	1.8M	▼-1.19%
6 May 2026	$2.22	$2.22	$2.09	$2.10	3.5M	▼-3.67%
5 May 2026	$2.20	$2.22	$2.17	$2.18	1M	▼-0.46%
4 May 2026	$2.18	$2.23	$2.18	$2.19	810K	▼-0.68%